Ticker Scorecard - GPCR Basics Company: Structure Therapeutics Inc. IPO Date: February 3, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.36B Activated in VL: True Average Daily Range Avg Daily Range: $1.20 | 3.22% Avg Daily Range (30 D): $0.72 | 2.64% Avg Daily Range (90 D): $0.97 | 3.03% Institutional Daily Volume Avg Daily Volume: .64M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 1,452 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $1.48M Avg Inst. Trade (90 D): $1.61M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.33M Avg Closing Trade (30 D): $1.13M Avg Closing Trade (90 D): $1.07M Avg Closing Volume: 32.46K     News Jun 17, 2024 @ 1:53 PM Could Structure Therapeutics Become the Next Novo ... Source: newsfeedback@fool.com (Alex Carchidi) Jun 13, 2024 @ 6:30 AM Pfizer: Headwinds Dissipating, New Obesity Pipelin... Source: ONeil Trader Jun 11, 2024 @ 1:59 PM Structure Therapeutics (GPCR) Rallying on Obesity ... Source: Zacks Equity Research Jun 11, 2024 @ 8:57 AM Structure Therapeutics Stock Could Rocket 87% High... Source: newsfeedback@fool.com (Cory Renauer) Jun 9, 2024 @ 11:30 AM Structure Therapeutics' Stock Is Soaring on the Pr... Source: newsfeedback@fool.com (Alex Carchidi) Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.72 $-.2 $-.18 Diluted EPS $-.72 $-.2 $-.18 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -110.55M $ -33.98M $ -26.03M Operating Income / Loss $ -142.16M $ -45.84M $ -33.32M Cost of Revenue $ $ $ Net Cash Flow $ 121.49M $ -209.5M $ 283.8M PE Ratio